CTLA4 and neoplasm: Cholangiocarcinomas exhibit expression of the immune checkpoint molecules, programmed cell death ligand 1 (PD-L1), and cytokine T-lymphocyte–associated protein 4 (CTLA-4), in the tumor microenvironment.